Co-Authors
This is a "connection" page, showing publications co-authored by Jehad Abubaker and Mohamed Abu-Farha.
Connection Strength
1.887
-
Impact of Diabetes in Patients Diagnosed With COVID-19. Front Immunol. 2020; 11:576818.
Score: 0.916
-
Molecular Simulation-Based Investigation of Highly Potent Natural Products to Abrogate Formation of the nsp10-nsp16 Complex of SARS-CoV-2. Biomolecules. 2021 04 14; 11(4).
Score: 0.235
-
Prognostic Genetic Markers for Thrombosis in COVID-19 Patients: A Focused Analysis on D-Dimer, Homocysteine and Thromboembolism. Front Pharmacol. 2020; 11:587451.
Score: 0.229
-
The Role of Lipid Metabolism in COVID-19 Virus Infection and as a Drug Target. Int J Mol Sci. 2020 May 17; 21(10).
Score: 0.221
-
Relevance between COVID-19 and host genetics of immune response. Saudi J Biol Sci. 2021 Nov; 28(11):6645-6652.
Score: 0.060
-
ACE2 and FURIN variants are potential predictors of SARS-CoV-2 outcome: A time to implement precision medicine against COVID-19. Heliyon. 2021 Feb; 7(2):e06133.
Score: 0.058
-
Higher binding affinity of furin for SARS-CoV-2 spike (S) protein D614G mutant could be associated with higher SARS-CoV-2 infectivity. Int J Infect Dis. 2021 Feb; 103:611-616.
Score: 0.057
-
Structural analysis of ACE2 variant N720D demonstrates a higher binding affinity to TMPRSS2. Life Sci. 2020 Oct 15; 259:118219.
Score: 0.056
-
The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Mol Ther Methods Clin Dev. 2020 Sep 11; 18:321-327.
Score: 0.056